Principal Financial Group
PETX

Principal Financial Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Principal Financial Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-19,343
Closed -$100K – 2294
2019
Q2 		$100K Buy
+19,343
New +$86.9K ﹤0.01% 2182
2019
Q1 		– Sell
-335,400
Closed -$2.06M – 2263
2018
Q4 		$2.06M Sell
335,400
-10,525
-3% -$64.2K ﹤0.01% 1711
2018
Q3 		$2.02M Sell
345,925
-9,475
-3% -$47.3K ﹤0.01% 1758
2018
Q2 		$1.51M Buy
355,400
+66,400
+23% +$335K ﹤0.01% 1783
2018
Q1 		$1.27M Sell
289,000
-1,900
-0.7% -$8.48K ﹤0.01% 1794
2017
Q4 		$1.53M Sell
290,900
-103,685
-26% -$634K ﹤0.01% 1790
2017
Q3 		$2.42M Buy
394,585
+3,200
+0.8% +$20.3K ﹤0.01% 1708
2017
Q2 		$2.83M Buy
391,385
+124
+0% +$763 ﹤0.01% 1707
2017
Q1 		$2.07M Sell
391,261
-5,700
-1% -$38.5K ﹤0.01% 1721
2016
Q4 		$2.85M Buy
396,961
+6,961
+2% +$56.3K ﹤0.01% 1662
2016
Q3 		$3.65M Hold
390,000
– – ﹤0.01% 1567
2016
Q2 		$2.46M Sell
390,000
-10,000
-3% -$64.3K ﹤0.01% 1625
2016
Q1 		$2.21M Hold
400,000
– – ﹤0.01% 1607
2015
Q4 		$2.23M Buy
400,000
+127,300
+47% +$841K ﹤0.01% 1611
2015
Q3 		$2.31M Buy
272,700
+14,200
+5% +$240K ﹤0.01% 1610
2015
Q2 		$3.91M Buy
258,500
+23,600
+10% +$341K 0.01% 1513
2015
Q1 		$3.76M Hold
234,900
– – 0.01% 1489
2014
Q4 		$4.19M Sell
234,900
-10,400
-4% -$130K 0.01% 1469
2014
Q3 		$2.46M Sell
245,300
-1,200
-0.5% -$14.5K ﹤0.01% 1611
2014
Q2 		$3.85M Sell
246,500
-8,000
-3% -$113K 0.01% 1512
2014
Q1 		$4.72M Hold
254,500
– – 0.01% 1392
2013
Q4 		$4.86M Sell
254,500
-95,500
-27% -$1.94M 0.01% 1361
2013
Q3 		$5.72M Hold
350,000
– – 0.01% 1172
2013
Q2 		$2.65M Buy
+350,000
New +$2.77M 0.01% 1514

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Principal Financial Group's PETX Position: Q3 2019 in Review

Principal Financial Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 19,343 shares — an estimated $100K sold.

Principal Financial Group first reported a position in PETX in Q2 2013 and held it in 24 quarters. The position peaked at $5.72M in Q3 2013. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Principal Financial Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Principal Financial Group sold 19,343 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $100K.
  • Principal Financial Group first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 24 quarters.
  • Principal Financial Group's Aratana Therapeutics, Inc. position peaked at $5.72M in Q3 2013.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Principal Financial Group's 13F filing for Q3 2019, filed 13 Nov 2019.